Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33345
Title: Atherosclerosis on CT coronary angiography and risk of long-term cardiovascular events post liver transplantation.
Austin Authors: Sampaio Rodrigues, Thalys ;Koshy, Anoop N ;Gow, Paul J ;Weinberg, Laurence ;Cailes, Benjamin ;Testro, Adam G ;Smith, Gerard;Lim, Han S ;Teh, Andrew W ;Lim, Ruth P ;Farouque, Omar 
Affiliation: Cardiology
Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.
Victorian Liver Transplant Unit
Anaesthesia
Radiology
Issue Date: 1-Feb-2024
Date: 2023
Publication information: Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024-02-01; 30(2)
Abstract: Computed tomography coronary angiography (CTCA) is increasingly utilized for pre-operative risk stratification prior to liver transplantation (LT). We sought to assess the predictors of advanced atherosclerosis on CTCA using the recently developed Coronary Artery Disease-Reporting and Data System (CAD-RADS) score and its impact on the prediction of long-term major adverse cardiovascular events (MACE) following LT. We conducted a retrospective cohort study of consecutive patients who underwent CTCA for LT work-up between 2011-2018. Advanced atherosclerosis was defined as coronary artery calcium scores (CACS) > 400 or CAD-RADS score ≥ 3 (≥ 50% coronary artery stenosis). Major adverse cardiovascular events were defined as myocardial infarction, heart failure, stroke or resuscitated cardiac arrest. Overall, 229 patients underwent CTCA (mean age 66 ± 5 y, 82% male). Of these, 157 (68.5%) proceeded with LT. The leading etiology of cirrhosis was hepatitis (47%), and 53% of patients had diabetes pre-transplant. On adjusted analysis, male sex (odds ratio [OR] 4.6, 95% confidence interval [CI] 1.5-13.8, p = 0.006), diabetes (OR 2.2, 95%CI 1.2-4.2, p = 0.01) and dyslipidemia (OR 3.1, 95%CI 1.3-6.9, p = 0.005) were predictors of advanced atherosclerosis on CTCA. Thirty-two patients (20%) experienced MACE. At a median follow-up of 4-years, CAD-RADS ≥ 3, but not CACS, was associated with a heightened risk of MACE (HR 5.8, 95%CI 1.6-20.6, p = 0.006). Based on CTCA results, 71 patients (31%) commenced statin therapy which was associated with a lower risk of all-cause mortality (HR 0.48, 95%CI 0.24-0.97, p = 0.04). The standardized CAD-RADS classification on CTCA predicted the occurrence of cardiovascular outcomes following LT, with a potential to increase utilization of preventive cardiovascular therapies.
URI: https://ahro.austin.org.au/austinjspui/handle/1/33345
DOI: 10.1097/LVT.0000000000000215
ORCID: 
Journal: Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
PubMed URL: 37432891
ISSN: 1527-6473
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

132
checked on May 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.